Daily Archives: July 28, 2023
UNESCO calls for global ban on smartphones in schools
28 Jul, 2023 | 14:26h | UTCReport: Technology in education – UNESCO
News Releases:
UNESCO calls for global ban on smartphones in schools – UN News
Smartphones in school? Only when they clearly support learning – UNESCO
Commentary: ‘Put learners first’: Unesco calls for global ban on smartphones in schools – The Guardian
WHO updates guidelines on fats and carbohydrates
28 Jul, 2023 | 14:25h | UTCNews Release: WHO updates guidelines on fats and carbohydrates – World Health Organization
Guidelines:
Carbohydrate intake for adults and children: WHO guideline – World Health Organization
Commentary on Twitter (thread – click for more)
Avoid #TransFats! Trans fats are found in
?️ baked & fried foods,
?️ pre-packaged snacks,
?️ meat & dairy foods from animals such as cows or sheep,
?️ processed foods.Limit your trans fats intake to less than 1% of total energy intake ?https://t.co/vCZlOtUeLj #HealthyDiets pic.twitter.com/l0ErFXvO4Q
— World Health Organization (WHO) (@WHO) July 17, 2023
New WHO lists of essential medicines
28 Jul, 2023 | 14:23h | UTCNews Release: WHO endorses landmark public health decisions on Essential Medicines for Multiple Sclerosis – World Health Organization
Lists of Essential Medicines
Model Lists of Essential Medicines – World Health Organization
Model Lists of Essential Medicines for Children – World Health Organization
Commentary on Twitter
OUT TODAY: New editions of the WHO Model Lists of Essential Medicines and Essential Medicines for Children which include important new medicines for the treatment of multiple sclerosis, cancer, infectious diseases and cardiovascular conditions, among others… pic.twitter.com/RZYdgc0i65
— World Health Organization (WHO) (@WHO) July 26, 2023
Study | Only 11% of sports supplements listing botanical ingredients accurately declare contents, 12% contain FDA-prohibited stimulants
28 Jul, 2023 | 14:21h | UTCCommentaries:
Ensuring the Safety and Value of Supplements – JAMA Network Open
BMJ Investigation | Medical royal colleges receive millions from drug and medical devices companies
28 Jul, 2023 | 14:19h | UTCMedical royal colleges receive millions from drug and medical devices companies – The BMJ
News Release: Medical royal colleges receive millions from drug/medical device companies – BMJ Newsroom
Commentary on Twitter
Drug and medical device companies have given £9m to UK royal colleges in recent years.
Scroll through our series of #BMJInfographics to see how much individual companies have paid each college ? https://t.co/s03xSl18BP pic.twitter.com/PX1Lzmtb4N
— The BMJ (@bmj_latest) July 27, 2023
JAMA guidance for authors, peer reviewers, and editors on use of AI, language models, and chatbots
28 Jul, 2023 | 14:18h | UTCGuidance for Authors, Peer Reviewers, and Editors on Use of AI, Language Models, and Chatbots – JAMA
See also, just published: New recommendations of the International Committee of Medical Journal Editors: use of artificial intelligence – European Heart Journal
Related
ChatGPT et al? Not So Fast, Say Journal Editors – TCTMD
Chat GPT will change Medicine – Vinay Prasad’s Observations and Thoughts
Can artificial intelligence help for scientific writing? – Critical Care
Artificial intelligence in academic writing: a paradigm-shifting technological advance
Perspective | Generating scholarly content with ChatGPT: ethical challenges for medical publishing
ChatGPT and the future of medical writing (ChatGPT itself wrote this paper)
ChatGPT is fun, but not an author – Science
Tools such as ChatGPT threaten transparent science; here are our ground rules for their use – Nature
ChatGPT listed as author on research papers: many scientists disapprove – Nature
Abstracts written by ChatGPT fool scientists
Study | New deep learning model effectively detects type 2 diabetes from chest X-rays
28 Jul, 2023 | 14:15h | UTC
Commentary on Twitter
"Your Chest-ray indicates you may have diabetes"https://t.co/1TEHWvG33D
The latest unexpected outgrowth of deep learning #AI @NatureComms @AyisPyrros and colleagues pic.twitter.com/wZcTT2GCy2— Eric Topol (@EricTopol) July 11, 2023
Position Paper | Prioritizing deprescribing in fall prevention strategies
28 Jul, 2023 | 14:12h | UTCOriginal Guideline: World guidelines for falls prevention and management for older adults: a global initiative – Age and Ageing
Review | Management of bleeding and hemolysis during percutaneous microaxial flow pump support
28 Jul, 2023 | 14:10h | UTC
Commentary on Twitter
Check out this practical guide for the management of bleeding/hemolysis with microaxial flow pump in #JACCINT's new state-of-the-art review: https://t.co/VSu31BPF5d#CardioTwitter @dirkwestermann @ABeneduceMD @MarioGramegnaMD pic.twitter.com/YuyinvWZ0L
— JACC Journals (@JACCJournals) July 26, 2023
Phase 2 Trial | Oral orexin receptor 2 agonist shows promise in narcolepsy type 1, but raises hepatotoxic concerns
28 Jul, 2023 | 14:09h | UTCOral Orexin Receptor 2 Agonist in Narcolepsy Type 1 – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
In a randomized trial involving patients with narcolepsy, an oral orexin receptor 2 agonist reduced sleepiness and cataplexy but had liver toxic effects. Read the full trial results: https://t.co/Go7lmQTu62
— NEJM (@NEJM) July 26, 2023
Cohort Study | Exploring the potential impact of artificial sweeteners on type 2 diabetes risk
28 Jul, 2023 | 14:07h | UTC
RCT | Liraglutide aids weight management in patients with suboptimal weight loss post metabolic surgery
28 Jul, 2023 | 14:05h | UTCSee also: Visual Abstract
